von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.

We recently reported that after activation of human platelets by thrombin, glycoprotein (GP) Ib-IX complexes are translocated to the surface-connected canalicular system (SCCS) (Blood 76:1503, 1990). As GPIb is a major receptor for von Willebrand factor (vWF) in platelet adhesion, we have now examined the consequences of thrombin activation on the organization of vWF bound to GPIb on the platelet surface. Studies were performed using monoclonal or polyclonal antibodies in either immunogold staining and electron microscopy (Au-EM) or in flow cytometry. When unstirred platelet-rich plasma was incubated with ristocetin, bound vWF was located by Au-EM as discrete masses regularly distributed over the cell surface. Platelets from a patient with Glanzmann's thrombasthenia, lacking GPIIb-IIIa complexes, gave a similar pattern, confirming that this represented binding to GPIb. That ristocetin was not precipitating vWF before their binding to the platelets was shown by the detection of similar masses on the surface of platelets of a patient with type IIB von Willebrand disease. Experiments were continued using washed normal platelets incubated in Tyrode-EDTA, the purpose of the EDTA being to limit the surface expression of endogenous vWF after platelet stimulation. Under these conditions, platelets were treated with ristocetin for 5 minutes at 37 degrees C in the presence of increasing amounts of purified vWF. This was followed by incubation with thrombin (0.5 U/mL) for periods of up to 10 minutes. Flow cytometry showed a time-dependent loss in the surface expression of vWF bound to GPIb and these changes were confirmed by Au-EM. In particular, immunogold staining performed on ultrathin sections showed that the bulk of the vWF was being cleared to internal membrane systems. Surface clearance of vWF during thrombin-induced platelet activation is a potential mechanism for regulating platelet adhesivity.

[1]  J. Lavergne,et al.  Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease. , 1991, Blood.

[2]  A. Girolami,et al.  Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. , 1990, The Journal of clinical investigation.

[3]  J. George,et al.  Glanzmann's thrombasthenia: the spectrum of clinical disease. , 1990, Blood.

[4]  M. Berryman,et al.  An enhanced method for post-embedding immunocytochemical staining which preserves cell membranes. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  R. Houghten,et al.  Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. , 1990, The Journal of biological chemistry.

[6]  G. Escolar,et al.  Receptor–ligand complexes are cleared to the open canalicular system of surface‐activated platelets , 1990, British journal of haematology.

[7]  H. Gralnick,et al.  Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets. , 1989, Blood.

[8]  M. Read,et al.  Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor , 1989 .

[9]  M. Berndt,et al.  Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. , 1988, Biochemistry.

[10]  P. Powers,et al.  von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP. , 1987, Blood.

[11]  JH Rand,et al.  Localization of surface vWF on resting and stimulated platelets. , 1987, Blood.

[12]  J. Mustard,et al.  Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. , 1987, Blood.

[13]  J. Sixma,et al.  Structure-function relationship of human von Willebrand factor. , 1987, Blood.

[14]  A. Girolami,et al.  Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. , 1987, The Journal of clinical investigation.

[15]  Xiaoping Du,et al.  Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. , 1987, Blood.

[16]  O. Behnke Surface membrane clearing of receptor-ligand complexes in human blood platelets. , 1987, Journal of cell science.

[17]  V. Woods,et al.  Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. , 1986, The Journal of biological chemistry.

[18]  J. Loscalzo,et al.  von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. , 1986, The Journal of clinical investigation.

[19]  K. Titani,et al.  The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. , 1986, The Journal of biological chemistry.

[20]  H. Gralnick,et al.  Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor. , 1986, Blood.

[21]  J. George,et al.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. , 1986, The Journal of clinical investigation.

[22]  K. Fujikawa,et al.  Human von Willebrand factor: a multivalent protein composed of identical subunits. , 1986, Biochemistry.

[23]  A. Girolami,et al.  Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Phillips,et al.  Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. , 1985, The Journal of biological chemistry.

[25]  J. George,et al.  Molecular defects in interactions of platelets with the vessel wall. , 1984, The New England journal of medicine.

[26]  J. Sixma,et al.  Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. , 1984, The Journal of clinical investigation.

[27]  M. Ginsberg,et al.  Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets. , 1984, The American journal of pathology.

[28]  D. Meyer,et al.  Inhibition of von Willebrand factor–platelet interaction by fibrinogen , 1984, Nature.

[29]  M. Shuman,et al.  Redistribution of alpha-granules and their contents in thrombin- stimulated platelets , 1984, The Journal of cell biology.

[30]  T. Fujimoto,et al.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. , 1982, The Journal of clinical investigation.

[31]  D. Zucker‐Franklin Endocytosis by human platelets: metabolic and freeze-fracture studies , 1981, The Journal of cell biology.

[32]  J. White,et al.  The surface-connected canalicular system of blood platelets--a fenestrated membrane system. , 1980, The American journal of pathology.

[33]  H. Gralnick,et al.  Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin. , 1977, The Journal of clinical investigation.

[34]  E. Kirby,et al.  The influence of Haemaccel, fibrinogen and albumin on ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of the ristocetin cofactor. , 1976, Thrombosis research.

[35]  J. White Uptake of latex particles by blood platelets: phagocytosis or sequestration? , 1972, The American journal of pathology.

[36]  J. White,et al.  Platelet membrane responses to surface and suspension activation. , 1990, Blood cells.

[37]  B. Coller,et al.  Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. , 1985, The Journal of clinical investigation.

[38]  B. Coller,et al.  Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor , 1983 .